Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-24 Purchase |
2022-10-26 8:02 pm |
Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner |
800,000 | $17 | $13,600,000 | 11,522,248 (Indirect) |
View |
| 2022-10-24 Purchase |
2022-10-26 8:01 pm |
Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
800,000 | $17 | $13,600,000 | 6,128,297 (Indirect) |
View |
| 2022-10-24 Purchase |
2022-10-26 8:01 pm |
Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner |
800,000 | $17 | $13,600,000 | 16,080 (Indirect) |
View |
| 2022-10-24 Purchase |
2022-10-26 8:00 pm |
Prime Medicine Inc. | PRME | Cahill Thomas Director |
400,000 | $17 | $6,800,000 | 5,305,679 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-31 Option Award |
2023-04-04 8:23 pm |
N/A 2033-03-31 |
Prime Medicine Inc. | PRME | Duffield Jeremy Chief Scientific Officer |
180,995 | $0 | 180,995 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-04 8:22 pm |
N/A 2033-03-31 |
Prime Medicine Inc. | PRME | Brudnick Richard Chief Business Officer |
135,747 | $0 | 135,747 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-04 8:22 pm |
N/A 2033-03-31 |
Prime Medicine Inc. | PRME | Gottesdiener Keith Michael See Remarks |
497,738 | $0 | 497,738 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-04 8:22 pm |
N/A 2033-03-31 |
Prime Medicine Inc. | PRME | LEE ANN L. Chief Technical Officer |
180,995 | $0 | 180,995 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-04 8:22 pm |
N/A 2033-03-31 |
Prime Medicine Inc. | PRME | Alenson Carman See Remarks |
90,498 | $0 | 90,498 (Direct) |
View |
| 2022-10-24 Conversion |
2022-10-26 8:02 pm |
N/A N/A |
Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner |
51,297,095 | $0 | 11,522,248 (Indirect) |
View |
| 2022-10-24 Conversion |
2022-10-26 8:01 pm |
N/A N/A |
Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
41,344,576 | $0 | 6,128,297 (Indirect) |
View |
| 2022-10-24 Conversion |
2022-10-26 8:01 pm |
N/A N/A |
Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner |
41,410,655 | $0 | 16,080 (Indirect) |
View |
| 2022-10-24 Conversion |
2022-10-26 8:00 pm |
N/A N/A |
Prime Medicine Inc. | PRME | Liu David R. 10% Owner |
1,321,666 | $0 | 21,156,945 (Direct) |
View |
| 2022-10-24 Conversion |
2022-10-26 8:00 pm |
N/A N/A |
Prime Medicine Inc. | PRME | Cahill Thomas Director |
20,156,459 | $0 | 5,305,679 (Indirect) |
View |
| 2022-10-24 Conversion |
2022-10-26 12:23 pm |
N/A N/A |
Prime Medicine Inc. | PRME | FMR LLC See Remark 1 |
8,462,946 | $0 | 4,228,589 (Indirect) |
View |
Ownership(A) |
2022-10-24 4:40 pm |
N/A N/A |
Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner |
0 | $0 | 16,080 (Indirect) |
View |
| 2022-10-19 Option Award |
2022-10-21 4:31 pm |
N/A 2032-10-19 |
Prime Medicine Inc. | PRME | Chung Wendy Director |
9,006 | $0 | 9,006 (Direct) |
View |
| 2022-10-19 Option Award |
2022-10-21 4:31 pm |
N/A 2032-10-19 |
Prime Medicine Inc. | PRME | Foster-Cheek Kaye I Director |
9,006 | $0 | 9,006 (Direct) |
View |
| 2022-10-19 Option Award |
2022-10-21 4:30 pm |
N/A 2032-10-19 |
Prime Medicine Inc. | PRME | Kelly Michael Aaron Director |
9,006 | $0 | 9,006 (Direct) |
View |
Ownership |
2022-10-19 8:24 pm |
N/A N/A |
Prime Medicine Inc. | PRME | FMR LLC See Remark 1 10% Owner |
0 | $0 | 8,462,946 (Indirect) |
View |
Ownership |
2022-10-19 8:08 pm |
N/A N/A |
Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 11,456,594 (Indirect) |
View |
Ownership |
2022-10-19 8:08 pm |
N/A N/A |
Prime Medicine Inc. | PRME | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2021 GP L.L.C. GV 2021 GP L.P. GV 2021 L.P. Alphabet Inc. 10% Owner |
0 | $0 | 12,484,688 (Indirect) |
View |
Ownership |
2022-10-19 8:08 pm |
N/A 2032-01-24 |
Prime Medicine Inc. | PRME | Foster-Cheek Kaye I Director |
0 | $0 | 13,510 (Direct) |
View |
Ownership |
2022-10-19 8:07 pm |
N/A 2031-11-24 |
Prime Medicine Inc. | PRME | Kelly Michael Aaron Director |
0 | $0 | 13,510 (Direct) |
View |
Ownership |
2022-10-19 8:07 pm |
N/A 2031-10-27 |
Prime Medicine Inc. | PRME | LEE ANN L. Chief Technical Officer |
0 | $0 | 562,917 (Direct) |
View |
Ownership |
2022-10-19 8:06 pm |
N/A N/A |
Prime Medicine Inc. | PRME | Liu David R. 10% Owner |
0 | $0 | 21,250,457 (Direct) |
View |
Ownership |
2022-10-19 8:06 pm |
N/A N/A |
Prime Medicine Inc. | PRME | Goldwasser Meredith SVP, Strategy & Corporate Ops. |
0 | $0 | 225,167 (Direct) |
View |
Ownership |
2022-10-19 8:05 pm |
N/A 2032-08-04 |
Prime Medicine Inc. | PRME | Brudnick Richard Chief Business Officer |
0 | $0 | 186,567 (Direct) |
View |
Ownership |
2022-10-19 8:05 pm |
N/A 2031-08-04 |
Prime Medicine Inc. | PRME | Alenson Carman See Remarks |
0 | $0 | 151,183 (Direct) |
View |
Ownership |
2022-10-19 8:04 pm |
N/A N/A |
Prime Medicine Inc. | PRME | Gottesdiener Keith Michael See Remarks |
0 | $0 | 4,602,328 (Direct) |
View |
Ownership |
2022-10-19 8:04 pm |
N/A 2031-11-24 |
Prime Medicine Inc. | PRME | Chung Wendy Director |
0 | $0 | 13,510 (Direct) |
View |
Ownership |
2022-10-19 8:03 pm |
N/A N/A |
Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner |
0 | $0 | 11,456,594 (Indirect) |
View |
Ownership |
2022-10-19 8:03 pm |
N/A N/A |
Prime Medicine Inc. | PRME | Cahill Thomas Director |
0 | $0 | 4,905,679 (Indirect) |
View |
Ownership |
2022-10-19 8:02 pm |
N/A N/A |
Prime Medicine Inc. | PRME | Duffield Jeremy Chief Scientific Officer |
0 | $0 | 981,084 (Direct) |
View |